PatentsGlobal
Rescheduling and Intellectual Property- What Medical Marijuana Operators Can (and Can’t) Do at the USPTO Now
When the acting attorney general moved state-licensed medical marijuana and FDA-approved marijuana-containing products from Schedule I to Schedule III, the headlines focused on ba…
When the acting attorney general moved state-licensed medical marijuana and FDA-approved marijuana-containing products from Schedule I to Schedule III, the headlines focused on banking, taxation, and what the change might mean for operators day to day. But one consequential — and underreported — area of impact is inte…
Monday, May 4, 2026
IIPLA News Desk